Marriott International, Inc. (NASDAQ: MAR) today announced that President and CEO Arne Sorenson was diagnosed on Wednesday with stage 2 pancreatic cancer. Sorenson, 60, received the diagnosis from a medical team at Johns Hopkins Hospital in Baltimore after a series of tests. Sorenson will remain in his role while undergoing treatment.
In a message to Marriott International associates, Sorenson noted: “The cancer was discovered early. It does not appear to have spread and the medical team – and I – are confident that we can realistically aim for a complete cure. In the meantime, I intend to continue working at the company I love. Let me make one request, look ahead with me. We have great work underway at Marriott. I am as excited by what we can accomplish together as I have ever been.”
Sorenson’s treatment plan will begin next week with chemotherapy. His doctors anticipate surgery near year end 2019.
